Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats
Background/Aim. Amifostine (AMI) is a broad-spectrum cytoprotector which protects against variety of radio- and chemotherapy-related toxicities without decreasing their antitumor action. The aim of the study was to investigate the potential protective effects of AMI against acute cardiotoxic eff...
Main Authors: | Dragojević-Simić Viktorija, Dobrić Silva, Jaćević Vesna, Bokonjić Dubravko, Milosavljević Ivica, Kovačević Aleksandra, Mikić Dragan |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2013-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2013/0042-84501200041D.pdf |
Similar Items
-
The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats
by: Vesna Jaćević, et al.
Published: (2018-08-01) -
Cytoprotective Efficacy of Amifostine Against Radiation- Induced Rectal Toxicity: Objective and Subjective Grading Scales for Radiomucositis
by: John R. Kouvaris, et al.
Published: (2008-04-01) -
Assessment of the Cytoprotective Efficacy of Amifostine with Quantitative Salivary Gland Scintigraphy
by: Bilgehan Karadayı, et al.
Published: (2005-01-01) -
Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study
by: C.A. De Souza, et al.
Published: (2000-07-01) -
Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation
by: S.C.M. Barbosa, et al.
Published: (2019-02-01)